Decreased MIG-6 expression can result from mutation of the MIG-6 coding region (in lung cancer) [52] or from MIG-6 promoter methylation (in papillary thyroid cancer) [53], but in CAH and EEC, the cause of MIG-6 loss is unknown. The gene discussed is ERRFI1; the disease is congenital adrenal hyperplasia.